Awarded to less than 5% of applicants, the grant accelerates Rubi's mission to decarbonize materials manufacturing. SAN FRANCISCO, Dec. 5, 2024 /PRNewswire/ -- Rubi, the company re-inventing ...
PARIS, France—Darexaban, a novel oral factor Xa inhibitor, was associated with a twofold to fourfold increased risk of major bleeding when added to aspirin and/or clopidogrel in patients with acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback